Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole.
about
Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Response to "Pharmacogenetics ...... rmacokinetics of Voriconazole.
@en
type
label
Response to "Pharmacogenetics ...... rmacokinetics of Voriconazole.
@en
prefLabel
Response to "Pharmacogenetics ...... rmacokinetics of Voriconazole.
@en
P2093
P2860
P356
P1476
Response to "Pharmacogenetics ...... rmacokinetics of Voriconazole.
@en
P2093
P2860
P356
10.1002/CPT.681
P407
P577
2017-04-29T00:00:00Z